Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      HomeBiotech

      Biotech

      IDEAYA Biosciences Announces Clinical Collaboration with Genentech in MTAP-Deleted KRAS G12D-Mutant Pancreatic Cancer
      Biotech

      IDEAYA Biosciences Announces Clinical Collaboration with Genentech in MTAP-Deleted KRAS G12D-Mutant Pancreatic Cancer

      August 19, 2026
      Rakovina Therapeutics Announces Results from 2026 Annual General Meeting
      Biotech

      Rakovina Therapeutics Announces Results from 2026 Annual General Meeting

      August 19, 2026
      Invitation to presentation of BioArctic’s second quarter report for April – June 2026 on August 26 at 9:30 a.m. CEST
      Biotech

      Invitation to presentation of BioArctic’s second quarter report for April – June 2026 on August 26 at 9:30 a.m. CEST

      August 19, 2026
      Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development
      Biotech

      Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development

      August 19, 2026
      Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia
      Biotech

      Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia

      August 18, 2026
      Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights
      Biotech

      Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights

      August 18, 2026
      HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Cancer After Progression on TAGRISSO®
      Biotech

      HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Cancer After Progression on TAGRISSO®

      August 17, 2026
      Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain
      Biotech

      Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain

      August 17, 2026
      argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis
      Biotech

      argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis

      August 17, 2026
      Cognizant and Benchling Selected as Partners to Accelerate Kyowa Kirin’s R&D
      Biotech

      Cognizant and Benchling Selected as Partners to Accelerate Kyowa Kirin’s R&D

      August 17, 2026
      « 1 … 10 11 12 13 14 … 212 »

       

      LATEST NEWS

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2026